Schedule 13G ownership disclosure
ORIC Pharmaceuticals Inc
Common Stock, $0.0001 par value per share · CUSIP: 68622P109
Event date: 2025-06-30
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Nextech Crossover I GP S.a. r.l.
Shares: 7,162,637.00 · Class: 8.4%
- Nextech Crossover I SCSp
Shares: 7,162,637.00 · Class: 8.4%
- Ian Charoub
Shares: 7,162,637.00 · Class: 8.4%
- Costas Constantinides
Shares: 7,162,637.00 · Class: 8.4%
- Rocco Sgobbo
Shares: 7,162,637.00 · Class: 8.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-25-021933
- Form type
- SCHEDULE 13G/A
- Filer
- Nextech Crossover I GP S.a r.l.
- CIK
- CIK 1916761
- Filed
- Aug 14, 2025
- Reporting period
- Jun 30, 2025
- Description
- Schedule 13G beneficial ownership